EUVIMEDEUVIMED entdecken
Crossref

Protein kinase Cι-driven macrophage infiltration mediates immunosuppression in non-small cell lung cancer

Shichuan Hu, Zichen Zhao, Jing Zhao, Yilin Liang, Lingye Zeng, Yifei Xia, Haoya Guo, Lili Jiang, Yan Zhang

Cancer Letters · 2026

DOI: 10.1016/j.canlet.2026.218330 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2026. Verfasst von Shichuan Hu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Lung Cancer Center/Lung Cancer Institute, West China Hospital, Sichuan University, Chengdu, 610041, China; Department of Biotherapy, Cancer Center an…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Protein Kinase C, Tumor-Associated Macrophages. Die Arbeit nennt 49 Literaturangaben. Gefördert von: Sichuan Provincial Science and Technology Support Program, Health Commission of Sichuan Province, Sichuan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non-small cell lung cancer (NSCLC) is the most common type of lung cancer and remains the leading cause of cancer-related mortality. Immune checkpoint inhibitors (ICIs) targeting the programmed death-1/programmed death ligand 1 (PD-1/PD-L1) axis can induce durable tumor regression in a subset of NSCLC patients; however, most exhibit resistance to ICIs therapy. Here, we identify the protein kinase Cι (PKCι)) as a biomarker and critical mediator of poor ICIs responsiveness in NSCLC. High PKCι expression correlates with resistance to anti-PD-1 antibody (αPD1) therapy, whereas low PKCι expression are highly sensitive. PKCι-dependent resistance to αPD1 is characterized by increased tumor-associated macrophages (TAMs) infiltration and reduced CD8+T cell numbers. Mechanistically, PKCι regulated Yap1-dependent transcription of CCL7, which recruits TAMs and fosters an immunosuppressive microenvironment. In contrast, Overexpression of PKCι or CCL7 in PKCι-knockdown tumors restores TAMs infiltration and αPD1 resistance. Pharmacological inhibition of PKCι with auranofin (AF) reduces TAMs accumulation and promotes CD8+T cell infiltration by inhibiting the PKCι-Yap1-CCL7 axis. Combination therapy with AF and αPD1 triggers a CD8+T cell-dependent antitumor immune response, thereby controlling tumor growth in situ or subcutaneously. In summary, our study reveals a PKCι-mediated immunosuppressive pathway driving ICIs resistance and support PKCι inhibition as a promising strategy to enhance immunotherapy efficacy in NSCLC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsProtein Kinase CTumor-Associated MacrophagesMacrophagesHumansProtein Kinase C-lambdaAnimalsIsoenzymesMiceTumor MicroenvironmentCell Line, TumorDrug Resistance, NeoplasmImmune Checkpoint InhibitorsFemaleCD8-Positive T-Lymphocytes

Stichwörter der Autor:innen

Immunotherapy resistanceNon-small cell lung cancerPKCιTumor-associated macrophages

Substanzen

Protein Kinase C-lambdaProtein Kinase CIsoenzymesImmune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Lung Cancer Center/Lung Cancer Institute, West China Hospital, Sichuan University, Chengdu, 610041, China; Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan Uni…
  • Lung Cancer Center/Lung Cancer Institute, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Department of Pathology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Lung Cancer Center/Lung Cancer Institute, West China Hospital, Sichuan University, Chengdu, 610041, China. Electronic address: zhang.yan@scu.edu.cn.

Förderung

  • Sichuan Provincial Science and Technology Support Program
  • Health Commission of Sichuan Province
  • Sichuan University
  • China Postdoctoral Science Foundation

Zitieren

APA

Hu, S., Zhao, Z., Zhao, J., Liang, Y., Zeng, L., Xia, Y., Guo, H., Jiang, L., & Zhang, Y. (2026). Protein kinase Cι-driven macrophage infiltration mediates immunosuppression in non-small cell lung cancer. Cancer Letters. https://doi.org/10.1016/j.canlet.2026.218330

Vancouver

Hu S, Zhao Z, Zhao J, Liang Y, Zeng L, Xia Y, et al. Protein kinase Cι-driven macrophage infiltration mediates immunosuppression in non-small cell lung cancer. Cancer Letters. 2026. doi:10.1016/j.canlet.2026.218330

BibTeX
@article{Hu2026,
  author = {Hu, Shichuan and Zhao, Zichen and Zhao, Jing and Liang, Yilin and Zeng, Lingye and Xia, Yifei and Guo, Haoya and Jiang, Lili and Zhang, Yan},
  title = {Protein kinase Cι-driven macrophage infiltration mediates immunosuppression in non-small cell lung cancer},
  journal = {Cancer Letters},
  year = {2026},
  doi = {10.1016/j.canlet.2026.218330}
}
Kostenlos starten →